Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
LOL. That and four quarters will get you a buck.
What is hilarious is that people think because PMCB is a 3 cent stock that its cheap. Here is a company with a 48 million dollar market cap that has in reality Nothing. No research facility, No research personnel, No facility at all. No data, no money, 1.3 Billion shares outstanding. No patents, No regulatory personnel, No ability to raise money other than selling shares at 75% discounts and then only enough to pay its crooked do nothing Management and paid for "Names". You basically are investing in Nothing when you buy PMCB.
Really. You mean Brokers are not "All In" on a 3 cent OTC stock that only issues Hype Pr's and sells Millions of shares at 75% discounts only to pay its Shady Management? A "Biotech" that has never released any data and spends 24k on R&D a month? I would think Buffet would be all over PMCB.
Shady Kenny's one day wonder pump comes sliding back down again today. Long term holders have made nothing on their investment while flippers and Kenny's .005 buyers are the only winners in the PMCB scam. And of course Shady and his pals have been winning for years.
I guess in the delusional world of PMCB the volume should be zero everyday with no one selling and therefore no one being able to buy. Wouldn't that be exciting.... LOL
Reading PMCB Quarterly and than pretending that something Biotech related is going on is not living in reality. It is all spelled out in black and white. 75k a Qtr on R&D and a Million on Salaries to a Lawyer, his penny stock scam partner and a bunch of pay for name usage people. Oh and don't forget the paid stock promotion by SMMG.
An alleged "Biotech" company that raises money by selling tens of millions of shares at half a penny and spends 95% of that money on paying Shady Kenny,friends and paid stock promotion has no "developments". Salaries is ALL PMCB is about and has ever been about so what else is there to talk about.
Be Ready for gap up now predicted for 15+ years.
Only in penny land could a company sell 70,000,000 shares of its stock for .005 a share and have the market share price remain at .035. On any real stock exchange the minute word got out of a sale like that the market price would drop to .005 or below. PMCB sells shares to 3rd party "friends" at .005 but only reports the sale in their 10q buried on the last pages and 90%+ of shareholders only read the PMCB Hype articles not the financials. This scam of a company will NEVER have any real investors because real investors read financial reports and PMCB"s is about as bad as a company could have. Selling shares by the tens of millions for half a penny every qtr, 1.3 BILLION shares outstanding, less than 75k spent on R&D and a MILLION on management + friends payouts. A 20+ year old technology that's only Non-FDA sanctioned trial was conducted in 1999. PMCB a company that has gone through three name changes and business models has raised and spent $100,000,000 over its 23 year history of Scam Artist Management (Now Multimillionaires) while producing absolutely NOTHING.
It made it sound like snake oil
That is exactly what it is. 20 years of selling CIAB as the "future of medicine" while producing no results and some really Shady people making a lot of money off Naive Investors.
SMMG getting involved more frequently is most likely a sign the buyer of the .005 shares is having problems dumping them. The future of all medicine now on sale for less than a penny a share. LOL!!!
Same paid for article over and over. PMCB a company that spend 24k a month on R&D changing the way Scam Biotech's are run.
Amazing that some cannot see that any possibility that their rights as shareholders to influence anything PMCB is now gone. Complain to IR, start petitions, yell and scream. Shady Kenny can do whatever he wants and there is not a thing any shareholder can do about it. PMCB/Nuvilex/Efood saftey has always been about one thing: Management getting paid.
The dumping of discounted shares will be ongoing as they are purchased every Qtr just to pay for what very little is being done. Its not like there are some discounted shares out there that need to be sold and that's it. Shady would have to sell something like 300,000,000 at .005 just to pay for IND filing fee.
What day to day operations expense does a company with no physical office space or R&D lab have. The G&A expense is all of the "Paid for PR consultants" so ya I add that into salaries. PMCB a "clinical stage Biotech" spends 24k a month on R&D that should be all one needs to know. ALL of the "Other" Money goes to Shady Kenny and Crew.
The financials of this PMCB scam are all you need to know. Right there in black and white every three months. A Million $ spent on salaries and 75k on R&D. Shares sold at half a penny by the tens of millions to finance theses salaries and no cash on hand to pay for any clinical trials not even enough to pay for half the IND fee. A penny stock scam company run by known penny stock scam artists with no Biotech experience. PMCB is in business to sell shares period. IMHO
It shows how long the CIAB Scam has been going on. An Austrianova press release is about as reliable as a Shady Kenny press release.
PhytoCeutica was developing a traditional Chinese medicine four-herb combination as a treatment for liver and pancreatic cancer. During his time with PhytoCeutica, Dr. Crabtree assumed ever-increasing responsibilities and from 2009 to 2010, ultimately serving as its Interim CEO. Dr. Crabtree resumed his consulting business after leaving PhytoCeutica until he joined PharmaCyte Biotech.
Sure because all the evidence shows what a "Real" company PMCB is. LOL
there's only one simple thing stopping pmcb from all of this big success,
They have a treatment that is not worth anything. No matter how many times some try to convince themselves otherwise. CIAB is a made up miracle cure fantasy for a Shady Washed up Lawyer and his pals to fund their retirement. No Interest from any real Biotech and selling shares at half a penny by the hundreds of millions. Run by a now 71 year old Lawyer that's previous position was at a Penny Stock Scam called Chinatel. Their CFO is also from this Scam Company. Their COO is a 78 year old former Doctor that also worked at a Chinese medical herb scam company. 8+ years PMCB has owned the rights to this treatment and No Pre-clinical data or Clinical data has ever been released. Not surprising seeing how only 74k of a Million$ + per qtr is spent on R&D. This company was founded in 1996 has changed business models 3 times and has been scamming money from investors for 23 Years.
Here you go.
https://stockprice.com/disclaimer/
At the bottom of the page under:
What we were paid.
(we will disclose our compensation, who paid us, how long we market for and how many shares we own below.)
2018 / 2019:
It is strange how some feel that Shady Kenny is overpaid and responsible for holding back the progress of CIAB when the fact is CIAB is the bogus tool Shady Kenny is using to overpay himself. If CIAB had any value a Shady Lawyer and His CFO pal from the Chinatel scam would not be the ones trying to bring it to market. Does anyone really believe if CIAB had any real potential any and i mean any potential some Biotech wouldn't have already bought it from PMCB which has owned it for EIGHT YEARS. PMCB the company that has to sell shares for half a penny can't find anyone to partner with the next great medical advancement or no body wants a useless product. Which seems 10,000 times more likely? PMCB is a penny stock scam using paid for names in fake paid for interviews. Never releasing any current FDA acceptable clinical or pre-clinical data to support eight years of bogus claims, spending less than 25k a month on R&D and 350k a month on Shady and Pal's pay.
Same people that hyped tattoo ink and Nuvilex's bird flu and natural cancer cure. 15+ years some have been hyping PMCB/Nuvilex/Efood Safety makes one wonder what motivates them.........
And the PMCB Stock Promotion Continues. Buyer of the .005 shares having a hard time unloading. LOL
Pursuant to an agreement between MIDAM VENTURES, LLC and Complete Investment And Management LLC, a Non-affiliate Third Party, Midam was hired for a period from 07/09/2019 – 8/09/2019 to publicly disseminate information about PharmaCyte Biotech including on the Website and other media including Facebook and Twitter. We were paid $150,000 (CASH) for & were paid “0” shares of restricted common shares. We were paid an additional $150,000 (CASH) BY Complete Investment And Management LLC, a Non-affiliate Third Party, AND HAVE EXTENDED coverage for a period from 8/12/2019 – 10/15/2019. We were paid an additional $150,000 (CASH) BY Complete Investment And Management LLC, a Non-affiliate Third Party, AND HAVE EXTENDED coverage for a period from 10/16/2019 – 11/15/2019.We may buy or sell additional shares of PharmaCyte Biotech in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.
Do you think Thermo Fisher will offer more than the going rate of .005 for PMCB? Maybe a bidding war will fetch .006.
Waggoner highlighted the 2016 milestones that PharmaCyte’s shareholders and investment community can look forward to this year:
The Austrianova manufacturing facility will become fully compliant with current Good Manufacturing Practices (cGMP) standards.
An Investigational New Drug Application (IND) will be filed with the FDA following a pre-IND meeting with the FDA.
Appropriate arrangements will be made with cancer centers in the United States to begin PharmaCyte’s pancreatic cancer trial that will address the critical unmet medical need that exists when a patient’s non-metastatic, pancreatic cancer no longer benefits from receiving the “gold standard” treatment – the combination of gemcitabine and Abraxane®.
PharmaCyte’s clinical trial in pancreatic cancer will get underway with Translational Drug Development (TD2) coordinating the trial globally and conducting it in the United States. Clinical Network Services (CNS) will conduct the trial in Europe and Australia in alliance with TD2.
After the pancreatic cancer clinical trial has been in process for approximately six months, there will be an evaluation of PharmaCyte’s pancreatic cancer treatment on the patients enrolled in the trial with the interim results being reported to the public.
Additional preclinical studies to determine if PharmaCyte’s pancreatic cancer treatment can slow down the production and accumulation of malignant ascites fluid will take place in 2016. If successful, plans to conduct a clinical trial in ascites will be undertaken by PharmaCyte with the goal of having TD2 begin the clinical trial by year end or early 2017.
Numerous preclinical studies will be conducted concurrently and in parallel by members of PharmaCyte’s international Diabetes Consortium to condense the time it will take for PharmaCyte to enter into a clinical trial that will test the ability of the Melligen insulin-producing cells encapsulated using the Cell-in-a-Box® technology to treat Type 1 diabetes and insulin-dependent Type 2 diabetes, with the goal of reaching the clinic in 2017.
PharmaCyte will fill its open Board of Directors positions as appropriate.
PharmaCyte will conduct periodic shareholder calls, rather than communicating through shareholder updates, with the CEO responding to questions during the calls.
PharmaCyte will hold an annual shareholder meeting.
PharmaCyte’s Chief Operating Officer, Dr. Gerald W. Crabtree stated, “2016 promises to be both busy and productive for the Company and those associated with it. Of course the major highlight will be the start of our clinical trial in pancreatic cancer.
Your petition is useless. Shady Kenny has complete control of PMCB and there is not a thing average shareholders can do about it.
Please post a link showing the FDA waiving IND fees. More false information.
Will his media coverage also start for the other Scam Company he represents besides PMCB when their "Trials Start soon" going on for a decade. A company making the same claims as PMCB with a market cap under 800k. These "Names" that PMCB promotes are all for hire people and bring nothing but PR Hype as a means to sell shares. Plain and simple.
https://ir.propanc.com/press-releases/detail/69/propanc-biopharma-engages-alan-morell-of-creative
A company that some claim is on the verge of "changing the way cancer is treated" spends 75k a Qtr. on R&D and over a $1,000,000 on paying a CEO Lawyer and his Pals. Sells shares by the hundreds of millions at 70% discounts and has a negative balance sheet. Looks like a scam acts like a scam. PMCB is a PR issuing shares selling Shady management paying SCAM.
.005 A SHARE
From August 1, 2019 through August 8, 2019, the Company sold 70,000,000 shares of common stock as a Block Trade using the S-3. The issuance of these shares resulted in gross proceeds to the Company of approximately $350,000.
.00695 A SHARE
May 1, 2019 through August 12, 2019, the Company sold 136,666,667 shares of common stock using the Second S-3 structured as a Block Trade. The issuance of these shares resulted in gross proceeds to the Company of approximately $950,000.
.0226 A SHARE
From May 1, 2018 through July 20, 2018, the Company sold 66,239,316 shares of common stock using the Second S-3 structured as aBlock Trade. The issuance of these shares resulted in gross proceeds to the Company of approximately $1,500,000.
Publicity campaign has started?
Published 3 months ago on July 8, 2019
Fact is the Publicity campaign has been ongoing for years. Its what PMCB is all about.
Nuvilex Names Kenneth L. Waggoner as President and CEO
November 25, 2013 10:17am
Nuvilex OTCNVLX today announced that Kenneth L. Waggoner, Esq. has been appointed Chief Executive Officer and President
Six Years later:
$Millions of Dollars made by Shady Kenny
Accomplishments = ZERO.
Try 71. And retired for 6 years now. Old Kenny loves his retirement pay even if he has to hock it .005 at a time.
As you can see the Investment community doesn't seam to think that David Judd's paid for PMCB "Interview" is worth very much. Shocking that the "Best of the Best" has so little influence to the Investment World. And WOW Thermo Fisher is involved look at the PPS and Volume skyrocket on the news. Some never learn. Year after year Shady trots out a "Name" for a PR Pump yet spends no money on R&D and longs proclaim buyouts and "best of the best" and start planning for retirement. Meanwhile Shady is laughing at all the cash he is already making IN RETIREMENT. LOL!!!!
You know a company is a scam when all they can produce after 7 years is interviews and fairy tale paid for articles. If PMCB was going to submit an IND soon there would be no need for these foolish "interviews" that are nothing more then paid for Hype. But keep buying because Kenny needs his $$.
How many? A never ending supply. PMCB has been and is continuing to sell hundreds of millions of share at less than a penny. They won't stop because it is the only means to raising money to pay Shady Kenny and Crew.
Keep averaging down that is what Shady Kenny is counting on. The more shares he sells the lower the price goes the more people need to average down. Its the penny stock circle of life. Always with the post of "can't believe i got these cheap shares" And of course the "price will never be this low again" until it is of course.
I have no idea what if any restrictions there are on these share sales. Nothing is mentioned that I can see in the 10q regarding restrictions.